Introduction: Endoscopic treatment of severe gastrointestinal bleeding can be difficult
and high technical expertise is required. A simple and effective method of endoscopic
hemostasis would have a significant impact on the treatment of active gastrointestinal
bleeding. Aim of the study is to assess the efficacy and safety of endoscopic hemostasis
with liquid combined activated factors IIa, VIIa, IXa, Xa (SerasealTM/Fastact, Wortham
Laboratories, Chattanooga, TN, USA).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2014 Published by Elsevier Inc.
